Table GPS-2. Last 12 months prevalence of drug use in nationwide surveys among the general population: last survey available for each Member State (from 2000 onwards) [see all tables in this series...]

Part (iii) Last 12 months prevalence 15 to 24 years old: last survey available for each Member State (from 2000 onwards)

Notes:

 (1) Cocaine, any form. 

 (2) For Belgium National 2001 and for Metropolitan France 1995: amphetamine and ecstasy, for Denmark National 1994: hard drugs. 

 (3) For Spain: ecstasy and other designer drugs. 

 This table aims to present an overview of national surveys. Exceptionally, some relevant regional surveys are presented. Some city surveys reported by countries were not included as they tend to produce higher prevalence estimates which are not comparable 

 In surveys with small sample sizes results should be interpreted with caution. 

 Countries were asked to report results using, as far as possible, EMCDDA standard age groups (all adults: 15–64, young adults: 15–34). In countries where age ranges are more restrictive, prevalence estimates tend to be slightly higher. Some countries have 

 For methods and definitions on population surveys in general, see General population surveys of drug use – methods and definitions. 

 For methods of each survey presented in this table, see Table GPS-7 part (i).  

 See also 'General notes for interpreting data' on the Explanatory notes and help page. 

Sources:

 See Table GPS-0. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)